Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Which numbing drug works best for dialysis access surgery?

NCT ID NCT07259772

First seen Dec 08, 2025 · Last updated Jun 17, 2026 · Updated 33 times

Summary

This study tests two numbing medicines, ropivacaine and lidocaine, in 40 adults with end-stage kidney disease who need surgery to create a blood vessel connection (fistula) for dialysis. Patients are randomly assigned to receive one of the two drugs during surgery, and neither they nor their surgeons know which one is used. Researchers measure pain levels, surgery time, need for extra pain relief, and how well the fistula works over the next 5 years. The goal is to find which drug provides better pain control and may improve long-term surgical success.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for END STAGE RENAL DISEASE (ESRD) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Lianyungang First People's Hospital

    Lianyungang, Jiangsu, 222000, China

Conditions

The condition(s) this trial relates to.

agnosia chronic kidney disease end stage renal failure

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.